Richard R Kew

US Patent:

20060094659, May 4, 2006

Filed:

Oct 5, 2005

Appl. No.:

11/243960

Inventors:

Richard Kew - Miller Place NY, US
Jianhua Zhang - Stony Brook NY, US

International Classification:

A61K 38/10
A61K 38/08
C07K 7/08
C07K 7/06

US Classification:

514013000, 514014000, 514015000, 514016000, 530326000, 530327000, 530328000

Abstract:

It has been demonstrated that one of Vitamin D Binding Protein (DBP) biological functions is to enhance the chemotactic activity of C5a and C5a des Arg. The present invention has found that peptides having sequences that substantially correspond to a specific region in the N-terminal domain I of DBP can block the DBP enhancement of C5a or C5a des Arg chemotactic activity. Based in this discovery the present invention provides DBP antagonist peptides and the use thereof for the treatment C5a or C5a des Arg-mediated disorders.